Press Releases

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Archives: Search / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013

 
From
To
Aug 12, 2022
DarioHealth Presents New Research Demonstrating the Ability to Support People in Rural Areas and Deliver Lasting Health Improvements

The research examines Dario's ability to improve the health of members in rural areas compared to their urban counterparts and found the solution to be equally effective NEW YORK, Aug. 12, 2022...

More
Aug 11, 2022
DarioHealth Selected by National Health Plan to Enhance Mental Health and Well-Being for Members

Dario's digital behavioral health solution will help to improve access and navigation across mental health resources NEW YORK, Aug. 11, 2022 /PRNewswire/ -- DarioHealth Corp. ("Dario",...

More
Aug 10, 2022
DarioHealth to Report Second Quarter 2022 Results on Monday, August 15

DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the second quarter ended June 30, 2022, on...

More
Aug 4, 2022
DarioHealth Presents New Research Demonstrating the Impact of a Digital Solution on Depression and Anxiety at the American Psychological Association Annual Convention

The studies underscore the value of Dario's integrated behavioral health solution to help more people connect to effective care that is right for their needs NEW YORK, Aug. 4, 2022 /PRNewswire/ --...

More
Jul 21, 2022
DarioHealth Demonstrates Continued Growth in Multi-Chronic Contracts with Latest Addition of a National Employer for the Full Solution Suite

Demand for Dario's single approach to chronic condition management continues to show strong demand NEW YORK, July 21, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global...

More
Jun 21, 2022
DarioHealth Announces New Contract with a National Employer

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced a new contract to deliver its digital behavioral health solution for a leading provider...

More
Jun 9, 2022
DarioHealth Secures $50 Million Dollar Non-Dilutive Credit Facility with OrbiMed

Investment from Elite Healthcare Fund Provides Validation, Access to Capital and Significant Runway to Execute on Strategic Operating Plan NEW YORK, June 9, 2022 /PRNewswire/ -- DarioHealth Corp....

More
Jun 3, 2022
DarioHealth Presents Three New Studies Demonstrating Improved Health in Users with Multiple Conditions at the American Diabetes Association's 82nd Scientific Sessions

The studies demonstrated significant improvement in glucose control and reductions in blood pressure for users managing diabetes and hypertension and improvement in clinical measures for users...

More
May 19, 2022
DarioHealth Announces Additional Commercial Contracts for its Digital Therapeutic Solutions

Two new B2B contracts reinforce Dario's position as an emerging leader in multi-chronic digital health NEW YORK, May 19, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the...

More
May 12, 2022
DarioHealth Reports Record Quarterly Revenues in its 2022 First Quarter

Total Q1 revenue of $8.06 million increased 124% over the comparable prior year period and 34% sequentially over Q4 2021 Accelerated Business-to-Business (B2B) transformation with 14 new B2B...

More
May 4, 2022
DarioHealth to Report First Quarter 2022 Results on Thursday, May 12

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the first quarter ended March 31, 2022 on...

More
Apr 27, 2022
DarioHealth Presents New Clinical Research Demonstrating Improved Outcomes for Participants Using a Single Integrated Digital Solution to Manage Multiple Chronic Conditions

New research offers fresh evidence that a single digital therapeutics platform can improve outcomes for commonly co-occurring conditions NEW YORK, April 27, 2022 /PRNewswire/ -- DarioHealth Corp....

More
1-25      26-50      51-75      76-100      101-125      126-150      151-175      176-200      201-225      226-250      251-275      276-300      301-325      326-350      351-375      376-400      401-425      426-450      451-475      476-500      501-515